Does DABRAFENIB Cause Metastases to liver? 134 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Metastases to liver have been filed in association with DABRAFENIB (Tafinlar). This represents 0.7% of all adverse event reports for DABRAFENIB.
134
Reports of Metastases to liver with DABRAFENIB
0.7%
of all DABRAFENIB reports
44
Deaths
42
Hospitalizations
How Dangerous Is Metastases to liver From DABRAFENIB?
Of the 134 reports, 44 (32.8%) resulted in death, 42 (31.3%) required hospitalization, and 7 (5.2%) were considered life-threatening.
Is Metastases to liver Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Metastases to liver?
LETROZOLE (1,295)
FULVESTRANT (1,241)
CAPECITABINE (1,061)
EVEROLIMUS (1,020)
RIBOCICLIB (967)
PACLITAXEL (885)
OCTREOTIDE (774)
BEVACIZUMAB (707)
FLUOROURACIL (630)
TAMOXIFEN (595)
Which DABRAFENIB Alternatives Have Lower Metastases to liver Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB